We are creating the first map of the druggable bioelectrome
The bioelectrome embodies the intricate network of bioelectric patterns and ionic currents that flow through every living entity, seamlessly connecting the microscopic realm of individual cells to the vast complexity of the entire organism.
By using multi-omics, bioelectric profiling and AI, we aim to exploit the electrical network controlling tissue repair and organ regeneration that exists throughout our bodies.
A team of innovators
We’re driven by the possibilities of regenerative medicine.
The bioelectrome is ancient and highly conserved
During development, the bioelectrome is a form of non-neural, multi-cellular cognition that knows what tissues to build and when to stop.
Unlocking its potential by using AI-driven technology to modulate ion channels as a conduit for bioelectric signaling will enable novel discoveries with a significant impact on human health.
Imagine the possibilities when we can direct cells to regenerate and repair damaged tissue
By understanding and manipulating the body’s bioelectric patterns, we can potentially rewrite them for the treatment of patients with many conditions that are currently inadequately addressed by other modalities, including traumatic injuries, degenerative diseases, and organ failure.
4.18.24
Morphoceuticals Names Jim Jenson, PhD as CEO to Advance AI-Guided Regenerative Medicine Technology
Company seeks to build the first map of the druggable bioelectrome
READ MORE >
PRESS RELEASE ARCHIVE >
